Natural Plastics

News about the bioplastics industry

Cardia secures expanded patent protection for its bioplastics technology

No comments :

Yoghurt Containers made from Cardia Biohybrid™ technology, now patent protected

Cardia Bioplastics Limited (ASX: CNN) has secured patent protection for its Cardia Compostable, Biohybrid™ and PPC-starch resin and finished products from Japan, Australia, New Zealand and China Patent and Trademark Offices. Seven new patents were granted during 2014 for Cardia’s unique and innovative bioplastics resin formulations and production processes.

These new patents expand Cardia Bioplastics growing intellectual property portfolio of 11 patent families, with 19 patents so far granted in USA, Australia, China, Japan, New Zealand and South Africa. The patents protect the composition formulation and manufacturing process invented by Cardia’s R&D team.

On receiving the news, Dr. Frank Glatz, Managing Director of Cardia Bioplastics said, “This marks an important milestone for Cardia Bioplastics. These granted patents protect the intellectual property of the Company and further support the technical differentiation of our globally certified Cardia Compostable and independently validated lower carbon foot print Cardia Biohybrid™ product offering.”

“Cardia is collaborating with leading global brand owners to reduce the environmental impact of their packaging. Cardia’s Biohybrid™ technology enables them to reduce the carbon footprint and the use of less oil in their packaging with an environmental benefit whilst maintaining product performance. Cardia’s strong patent position and freedom to operate is a critical requirement for these large global brand owners.”

Richard Tegoni Cardia Bioplastics Chairman stated, “Protecting Cardia’s intellectual property is a high priority as it supports our businesses long-term growth strategy of creating new Compostable and Biohybrid™ resins that meet the needs of the growing market for resins and finished products.”

The continual expansion of Cardia’s patent portfolio validates Cardia’s technical capabilities and unique formulation. With rapid global growth of bioplastics use in diverse product applications, Cardia’s patent portfolio capitalizes on the demand of leading brand owners where strong intellectual property position is a key requirement.

Leading German Consumer Goods Company chooses Cardia Biohybrid™ technology

No comments :

  • image

Extrusion blow moulded bottles made with Cardia Biohybrid™ technology

Cardia Bioplastics Limited  is pleased to announce that a leading German Consumer Goods Company has chosen Cardia Biohybrid™ technology for their product packaging.
Following four years rigorous quality and performance testing, the German Consumer Goods Company, which can not be named for commercial reasons, has chosen Cardia Biohybrid™ technology for their product packaging.

Cardia Biohybrid™ technology was validated in a stringent approval process for high performance rigid packaging applications including – quality, performance, price, environmental claims, intellectual property position and freedom to operate.

The Cardia Biohybrid™ technology had to satisfy full food safety compliance as well as deliver superior packaging performance through the product life cycle.

As a European market leader, the German Consumer Goods Company is redefining packaging with a European market launch of Cardia Biohybrid™ technology packaging in early 2015.

The German major placed initial container orders.  The business has the capacity to expand rapidly due to the company’s market presence within the Fast Moving Consumer Goods category.

Cardia Bioplastics Managing Director Dr Frank Glatz said: “Collaborating with this well-known German Consumer Goods Company presented an exciting opportunity to develop high performance packaging with lower environmental impact. In addition to offering a product with beneficial environmental profile and full food safety compliance, a key criterion for success was in delivering superior packaging performance through the entire product life cycle.”

“In addition to meeting all product performance criteria, the tests confirmed that our Biohybrid™ technology enhanced the shelf life of the packaged product due to its good gas barrier properties. This is a real value add outcome for our customer,” Dr Glatz added.

Meeting the stringent testing and approval process of the German consumer goods company further validates Cardia Biohybrid™ versatility in product applications, its environmental benefits and product performance.

Cardia continues to be well positioned in benefiting from the trend towards sustainable packaging. Offering customers the choice of using sustainable Cardia Biohybrid™ technology (less oil, lower carbon foot print) or Compostable technology (delivering certified compostability to international standards); Cardia is continuing to see increased demand in a broad range of applications, including flexible film, bag, injection moulding and blow moulding applications.